Characterization of Cholesterol Pathways in ALD Pathophysiology
Dr. Josh Bonkowsky 2025 Annual Meeting and Patient Learning Academy
▶︎
The Grey Zone Project Risk-Based Classification of ABCD1 Variants in X-linked Adrenoleukodystrophy
▶︎
Gene Therapy Vectors
▶︎
Keynote: Joe McCann - The future of Canadian radiotheranostics: Reaching criticality | CRLS 2026
▶︎
POCT in GM: Sarah Rickard & Dwaipayan Sen
▶︎
How to Focus to Change Your Brain | Huberman Lab Essentials
▶︎
Building the Future for ALD: Paradigm Shifts and Therapeutic Opportunities
▶︎
Two Tales to Tell: Gene Therapy 2.0 and Anti-MLC
▶︎
Before You Panic Over Your DEXA Score, Watch THIS
▶︎
What do tech pioneers think about the AI revolution? - The Engineers, BBC World Service
▶︎
CSHL Keynote, Dr. David Liu, Broad Institute of Harvard and MIT
▶︎
"The Future of Osteoporosis Treatment" by Dr. Marc N. Wein, MD., PHD
▶︎
Combination Therapy: Medication Strategies for Hard-to-Treat Complex ADHD (w/ Timothy Wilens, M.D.)
▶︎
Gene Editing Approaches
▶︎
Dr. Chris Palmer | Brain Energy: The Metabolic Theory of Mental Illness | The Metabolic Link Ep. 47
▶︎
Hope Is Here: A Breakthrough Moment for the IgG4-RD Community
▶︎
Curing vs. Caring: Dr. Kleinman on Communication, Empathy, and the Role of the Physician
▶︎
Machine Learning in Drug Discovery Symposium: Keynote, Tom Miller
▶︎
ADD/ADHD | What Is Attention Deficit Hyperactivity Disorder?
▶︎
HRS 2025: Rhythm Theater | AI and PFA: A Complementary Approach to Arrhythmia Treatment
▶︎